Hallucinogen Use is Associated with Mental Health and Addictive Problems and Impulsivity in University Students.
addiction
drugs
hallucinogens
illicit
impulsivity
Journal
Addictive behaviors reports
ISSN: 2352-8532
Titre abrégé: Addict Behav Rep
Pays: Netherlands
ID NLM: 101656077
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
entrez:
5
12
2019
pubmed:
5
12
2019
medline:
5
12
2019
Statut:
ppublish
Résumé
This study examined the prevalence of hallucinogen use in a large sample of university students and its associations with mental health issues. 9,449 students received a 156-item anonymous online survey, which assessed the use of hallucinogens (ever or past year), alcohol and drug use, mental health issues, and impulsive and compulsive traits. Group differences were characterized using statistical tests (p values reported uncorrected, but only regarded as significant if surviving Bonferroni correction). 3,525 university students (57.7% female) responded to the survey. The prevalence of past 12-month hallucinogen use in the sample was 4.7%, with an additional 6.4% reporting having used more than 12 months ago. Hallucinogen use was associated with the use of multiple other drugs (e.g., alcohol, opiates) (each p<0.001), mental health problems (p<0.001), risky sexual behavior (p<0.001), low self-esteem (p=0.004), and impulsivity traits (p<0.001) but not compulsivity. Effect sizes were small to medium. Past use of hallucinogens was reported in 11.1%, and was associated with a variety of mental health and drug use problems. Clinicians should be aware that use of hallucinogens is common and mental health problems are more likely in those who use hallucinogens. This study indicates the need for longitudinal research into the negative effects of hallucinogen use on brain function and mental health, especially in young people. Such research should address the extent to which impulsive traits predispose to various substance use problems, versus the direct effects of hallucinogens (and other substances) on mental health.
Sections du résumé
BACKGROUND
BACKGROUND
This study examined the prevalence of hallucinogen use in a large sample of university students and its associations with mental health issues.
METHODS
METHODS
9,449 students received a 156-item anonymous online survey, which assessed the use of hallucinogens (ever or past year), alcohol and drug use, mental health issues, and impulsive and compulsive traits. Group differences were characterized using statistical tests (p values reported uncorrected, but only regarded as significant if surviving Bonferroni correction).
RESULTS
RESULTS
3,525 university students (57.7% female) responded to the survey. The prevalence of past 12-month hallucinogen use in the sample was 4.7%, with an additional 6.4% reporting having used more than 12 months ago. Hallucinogen use was associated with the use of multiple other drugs (e.g., alcohol, opiates) (each p<0.001), mental health problems (p<0.001), risky sexual behavior (p<0.001), low self-esteem (p=0.004), and impulsivity traits (p<0.001) but not compulsivity. Effect sizes were small to medium.
CONCLUSION
CONCLUSIONS
Past use of hallucinogens was reported in 11.1%, and was associated with a variety of mental health and drug use problems. Clinicians should be aware that use of hallucinogens is common and mental health problems are more likely in those who use hallucinogens. This study indicates the need for longitudinal research into the negative effects of hallucinogen use on brain function and mental health, especially in young people. Such research should address the extent to which impulsive traits predispose to various substance use problems, versus the direct effects of hallucinogens (and other substances) on mental health.
Identifiants
pubmed: 31799366
doi: 10.1016/j.abrep.2019.100228
pmc: PMC6887552
mid: EMS84748
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Wellcome Trust
ID : 110049
Pays : United Kingdom
Références
J Psychopharmacol. 2016 Dec;30(12):1268-1278
pubmed: 27578767
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
Psychiatry Res. 2018 Jul;265:279-283
pubmed: 29772488
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:237-49
pubmed: 25818246
Addict Behav. 2019 Feb;89:35-43
pubmed: 30245407
Drug Alcohol Depend. 2009 Sep 1;104(1-2):156-66
pubmed: 19500920
Psychol Med. 2005 Feb;35(2):245-56
pubmed: 15841682
CNS Spectr. 2018 Oct;23(5):340-346
pubmed: 29730994
Int J Methods Psychiatr Res. 2007;16(2):52-65
pubmed: 17623385
J Subst Abuse Treat. 2007 Mar;32(2):189-98
pubmed: 17306727
Prog Brain Res. 2018;242:69-96
pubmed: 30471683
Am J Psychiatry. 1968 May;124(11):1483-90
pubmed: 4384739
J Psychopharmacol. 2015 Mar;29(3):280-8
pubmed: 25586402
Lancet. 2002 May 25;359(9320):1866
pubmed: 12044415
Addiction. 2019 Jun;114(6):1095-1109
pubmed: 30133930
PLoS One. 2013 Aug 19;8(8):e63972
pubmed: 23976938
Am J Psychiatry. 1969 Oct;126(4):565-9
pubmed: 5806803
J Psychopharmacol. 2015 Mar;29(3):289-99
pubmed: 25586396
Addict Behav. 1982;7(4):363-71
pubmed: 7183189
J Clin Psychol. 1995 Nov;51(6):768-74
pubmed: 8778124
Psychopharmacology (Berl). 1999 Oct;146(4):348-61
pubmed: 10550486
Neurosci Lett. 2017 May 10;649:176-180
pubmed: 27394687
Psychol Med. 2018 Apr;48(5):810-821
pubmed: 28805173
Sci Rep. 2017 Oct 13;7(1):13187
pubmed: 29030624
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941